Broadfin Healthcare Master Fund Ltd Insider Trading $PGNX PROGENICS PHARMACEUTICALS INC
Get free email notifications about insider trading for Broadfin Healthcare Master Fund Ltd.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Broadfin Healthcare Master Fund Ltd. Broadfin Healthcare Master Fund Ltd is 10% Owner in NOVELION THERAPEUTICS INC. ($QLTI) and Director in NOVELION THERAPEUTICS INC. ($NVLN) and 10% Owner in PROGENICS PHARMACEUTICALS INC ($PGNX) and 10% Owner in AVADEL PHARMACEUTICALS PLC ($FLML) and Director in BIODELIVERY SCIENCES INTERNATIONAL INC ($BDSI) and 10% Owner in STRATA Skin Sciences, Inc. ($MELA) and 10% Owner in Aegerion Pharmaceuticals, Inc. ($AEGR) and 10% Owner in ARATANA THERAPEUTICS, INC. ($PETX) and 10% Owner in Mirati Therapeutics, Inc. ($MYG) and 10% Owner in Corium International, Inc. ($CORI) and 10% Owner in Recro Pharma, Inc. ($REPH).
Broadfin Healthcare Master Fund Ltd in PROGENICS PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Broadfin Healthcare Master Fund Ltd: 10% Owner
Holdings: 7,499,869 shares
Current Value: $71,473,752
Latest Transaction: Feb 15 2017
$PGNX Market Capitalization: $671.09M
$PGNX Previous Close: $9.53
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Broadfin Healthcare Master Fund Ltd in PROGENICS PHARMACEUTICALS INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AEGR, PETX, AVDL, BDSI, CORI, MYG, NVLN, PGNX, REPH, MELA
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 15 2017 | PGNX | PROGENICS PHARMACE ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.55 | 150,000 | 1,432,500 | 6,997,269 | 7.1 M to 7 M (-2.10 %) |
| Feb 15 2017 | PGNX | PROGENICS PHARMACE ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.68 | 150,000 | 1,452,000 | 7,147,269 | 7.3 M to 7.1 M (-2.06 %) |
| Feb 15 2017 | PGNX | PROGENICS PHARMACE ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.70 | 100,000 | 970,000 | 7,297,269 | 7.4 M to 7.3 M (-1.35 %) |
| Feb 15 2017 | PGNX | PROGENICS PHARMACE ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.70 | 50,000 | 485,000 | 7,397,269 | 7.4 M to 7.4 M (-0.67 %) |
| Feb 15 2017 | PGNX | PROGENICS PHARMACE ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.70 | 52,600 | 510,220 | 7,447,269 | 7.5 M to 7.4 M (-0.70 %) |
| Feb 15 2017 | PGNX | PROGENICS PHARMACE ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.70 | 100,000 | 970,000 | 7,499,869 | 7.6 M to 7.5 M (-1.32 %) |
| Feb 09 2017 | PGNX | PROGENICS PHARMACE ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.69 | 1,300 | 12,591 | 7,599,869 | 7.6 M to 7.6 M (-0.02 %) |
| Feb 09 2017 | PGNX | PROGENICS PHARMACE ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.66 | 100,000 | 966,000 | 7,601,169 | 7.7 M to 7.6 M (-1.30 %) |
| Feb 09 2017 | PGNX | PROGENICS PHARMACE ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.75 | 100,000 | 975,000 | 7,701,169 | 7.8 M to 7.7 M (-1.28 %) |
| Feb 09 2017 | PGNX | PROGENICS PHARMACE ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.65 | 50,000 | 482,500 | 7,801,169 | 7.9 M to 7.8 M (-0.64 %) |
| Feb 09 2017 | PGNX | PROGENICS PHARMACE ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | S | 9.74 | 100,000 | 974,000 | 7,851,169 | 8 M to 7.9 M (-1.26 %) |
| Jan 13 2017 | PGNX | PROGENICS PHARMACE ... | Broadfin Healthcare Master Fun ... | 10% Owner | Sell | D | 8.95 | 1,000,000 | 8,950,000 | 7,951,169 | 9 M to 8 M (-11.17 %) |
| Jul 23 2014 | PGNX | PROGENICS PHARMACE ... | Broadfin Healthcare Master Fun ... | 10% Owner | Buy | P | 4.73 | 388,659 | 1,838,357 | 8,951,169 | 8.6 M to 9 M (+4.54 %) |
| Jul 23 2014 | PGNX | PROGENICS PHARMACE ... | Broadfin Healthcare Master Fun ... | 10% Owner | Buy | P | 4.73 | 388,200 | 1,836,186 | 8,562,510 | 8.2 M to 8.6 M (+4.75 %) |
| Jul 23 2014 | PGNX | PROGENICS PHARMACE ... | Broadfin Healthcare Master Fun ... | 10% Owner | Buy | P | 4.48 | 436,884 | 1,957,240 | 8,174,310 | 7.7 M to 8.2 M (+5.65 %) |
| Jul 23 2014 | PGNX | PROGENICS PHARMACE ... | Broadfin Healthcare Master Fun ... | 10% Owner | Buy | P | 4.48 | 411,693 | 1,844,385 | 7,737,426 | 7.3 M to 7.7 M (+5.62 %) |
Page: 1